Blog

Start-up stories: From science to business

Their first pitch deck didn’t contain a business slide. And there wasn’t any information on market potential. These were things that Dr Isabel Schellinger and Dr Uwe Raaz simply hadn’t thought of. After all, their focus was on their research, on the amazing opportunities made possible thanks to science, and on a medical solution to an aortic disorder in humans that they had developed. This is their passion and their field of expertise. Pitching to investors and founding a start-up were things that they first needed to learn.

Today, the two of them are successfully running their medtech start-up Angiolutions, a HTGF portfolio company that was founded in 2020 in the middle of the pandemic. The two doctors conducted research together at Stanford. Building on their research work, they came up with the idea of a novel vascular implant to treat aortic aneurysms. The aorta plays an absolutely vital role, carrying oxygen-rich blood from the heart to the rest of the body. It has a diameter of 2.5 to 3.5cm. If the aorta becomes enlarged and then bulges, it can present a major risk. This is known as an aneurysm. If the aorta tears or bursts, it can be life-threatening. A bulging aorta is like a ticking time bomb, with its diameter increasing by around 2.5mm per year. Around 4-8 percent of men around the world suffer from abdominal aortic aneurysms.

Thanks to Angiolutions’s device-based therapy, doctors now for the first time have access to a minimally invasive, low-risk treatment option that prevents small aortic aneurysms from growing in size.

In this episode of our “Start-up stories” series of short videos, Dr Isabel Schellinger and Dr Uwe Raaz tell us about their journey into the world of business and offer some tips on founding a start-up in the field of science. Here’s a little teaser of what they have to say: As is so often the case, the key is to identify a genuine medical need or a genuine customer need. Get support from good partners. And don’t forget to put a business slide in your pitch deck.

A big thank you to Isabel and Uwe for all their insights!

Are you a medtech entrepreneur or looking to found a start-up in this field? Share your experiences and ideas with Principal Anke Caßing. She looks forward to hearing from you.

More Blog posts

Blog
Verena Pausder - Interview
23. April 2024

Interview with Verena Pausder: Entrepreneurial awakening – make it in Germany!

Verena Pausder, Chairwoman of the German Startup Association At Family Day 2024, you’ll be calling for an “entrepreneurial awakening” and for companies to “make it in Germany”. How can this happen?If “Made in Germany” was a seal of quality in the past, then I believe that “Make it in Germany” should be our objective for the future.This can be achieved by supporting a start-up culture that welcomes diversity and talented individuals from around the world. Germany should s
 
Blog
22. March 2024

Successful pitches: 10 tips for an impressive pitch deck 

In their day-to-day work, Kilian von Berlichingen, Senior Investment Manager at HTGF, and Arnas Bräutigam, Co-Founder of AddedVal.io, look at numerous pitch decks critically. In this blog post, they provide a series of tips on how you can avoid making the most common mistakes in your pitch deck. from left: Arnas Bräutigam, Co-Founder of AddedVal.io and Kilian von Berlichingen, Senior Investment Manager at HTGF 1. Keep your pitch deck short and sweet:Your pitch deck should be prec
 
Blog
22. February 2024

Digital health investments: Road to success requires bold steps and an interdisciplinary approach

Since as far back as 2012, High-Tech Gründerfonds has been investing in start-ups that operate at the intersection between healthcare and digital solutions. In this interview, our Senior Investment Managers Louis Heinz (Digital Tech) and Niels Sharman (Life Sciences) share some insights into the synergies that arise from the HTGF team’s diverse perspectives and also give their take on where the sector stands in Germany and internationally. Louis Heinz and Niels Sharman, Senior Investme